| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 02/06/2013 | EP2552886A1 Cytokine inhibitors |
| 02/06/2013 | CN202715268U 结晶器 Mold |
| 02/06/2013 | CN102911104A Method for preparing pyrrole derivative with sulfonyl on alpha-substituent |
| 02/06/2013 | CN102911103A 1-(3, N, N-disubstituted amino group propyl group)-pyrrolidone derivative and preparation method thereof |
| 02/06/2013 | CN102909074A Immobilized type non-toxic catalyst and method for synthesizing N-phenylmaleimide and N-substitutional phenylmaleimide |
| 02/06/2013 | CN101925576B Kappa selective opioid receptor antagonist |
| 02/06/2013 | CN101711106B Pharmaceutical use of substituted amides |
| 02/06/2013 | CN101448807B Production of 2,5-dihydrofurans and analogous compounds |
| 02/05/2013 | US8367848 Process for the preparation of amorphous calcium salt of atorvastatin |
| 02/05/2013 | US8367844 Microbiocidal heterocycles |
| 02/05/2013 | US8367677 Non-glycosylated/non-glycosidic/non-peptidic small molecule PSGL-1 mimetics for the treatment of inflammatory disorders |
| 02/05/2013 | US8367065 Targeted polymeric prodrugs containing multifunctional linkers |
| 02/05/2013 | US8366956 Quaternary ammonium salt and composition, and electrochemical device |
| 02/05/2013 | CA2549741C Reagent for detecting an analyte |
| 02/05/2013 | CA2519250C Therapeutic agent for diabetes mellitus |
| 01/31/2013 | WO2013014604A1 Multicomponent crystalline system of ezetimibe and proline |
| 01/31/2013 | US20130030184 Isotopically labeled chemically stable reagents and process for the synthesis thereof |
| 01/31/2013 | US20130028843 Kallikrein 7 modulators |
| 01/31/2013 | US20130026458 Crosslinkable composition |
| 01/31/2013 | US20130025495 Compositions comprising a reactive monomer and uses thereof |
| 01/31/2013 | CA2841655A1 Multicomponent crystalline system of ezetimibe and proline |
| 01/30/2013 | CN202705271U N-methylprolinodone (NMP) recycling device capable of water cooling and air cooling |
| 01/30/2013 | CN102898345A Preparation method of N-(2, 4, 6-trichlorophenyl) maleimide |
| 01/30/2013 | CN102898344A Br[phi]nsted acidic compound containing amide groups, and preparation method and application thereof |
| 01/30/2013 | CN102898343A Method for preparing poly-substituted pyrrole derivatives |
| 01/30/2013 | CN102898342A Chiral compound |
| 01/30/2013 | CN101786962B Method for producing amino acid chelate iron |
| 01/30/2013 | CN101631760B Catalytic method for producing (meth) acrylic acid esters of N-hydroxyalkylated lactams |
| 01/30/2013 | CN101528681B New sulfonamide derivatives as bradykinin antagonists |
| 01/29/2013 | US8362278 Methods for the conversion of a substituted furan to a substituted pyrrole |
| 01/29/2013 | US8362276 Reacting a vinyl sulfone compound with imide compound in presence of catalyst |
| 01/29/2013 | US8362274 Arylalkylamine compound and process for preparing the same |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 01/29/2013 | US8362144 Monomers for making polymeric cell culture surface |
| 01/29/2013 | US8362035 Crystalline forms of a potent HCV inhibitor |
| 01/29/2013 | US8362025 Compositions useful for treating disorders related to TRPA1 |
| 01/29/2013 | US8362020 Hepatitis C virus inhibitors |
| 01/29/2013 | US8362003 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 01/29/2013 | US8361994 Primary amine diazeniumdiolate heterocyclic derivatives |
| 01/29/2013 | US8361442 Oxime conjugates and methods for their formation and use |
| 01/29/2013 | CA2694835C Novel crystalline form |
| 01/29/2013 | CA2583918C Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 01/29/2013 | CA2583457C Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |
| 01/24/2013 | WO2013013026A1 Carboxylic pyrrolidinones and methods of use thereof |
| 01/24/2013 | WO2013012987A1 Overbased friction modifiers and methods of use thereof |
| 01/24/2013 | WO2013012829A1 Diaminocyclohexane compounds and uses thereof |
| 01/24/2013 | WO2013011999A1 Method for producing optically active 2-methylproline derivative |
| 01/24/2013 | WO2013011887A1 Method for producing (2s, 4s)-1-hydroxyacetyl-2-aminocarbonyl-4-fluoropyrrolidine |
| 01/24/2013 | US20130023539 Pyrrolidine or thiazolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disorders as agonists of g-protein coupled receptor 43 (gpr43) |
| 01/24/2013 | US20130023503 Nk1 antagonists |
| 01/24/2013 | US20130023056 Early detection of recurrent breast cancer using metabolite profiling |
| 01/24/2013 | CA2842669A1 Overbased friction modifiers and methods of use thereof |
| 01/24/2013 | CA2842660A1 Carboxylic pyrrolidinones and methods of use thereof |
| 01/23/2013 | CN1606545B Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/23/2013 | CN102887852A Preparation method of N-(p-methoxyphenyl)maleimide |
| 01/23/2013 | CN102887851A Compound 3,5-dimethyl-1H-pyrrole-2,4-diformaldehyde and preparation method thereof |
| 01/23/2013 | CN102887850A Pyridine-ion-containing liquid, preparation method and application thereof |
| 01/23/2013 | CN101973922B Atorvastatin semi-strontium salt polymorphs as well as preparation and application thereof as HMG-CoA enzyme inhibitor |
| 01/23/2013 | CN101565393B 3-(substituted bisulfonyl fluromethane)-1-propylene compound, synthetic method and applications thereof |
| 01/23/2013 | CN101062913B Preparation method of hydroxyproline-zinc chelate complex |
| 01/22/2013 | US8357710 Bicyclic angiotensin II agonists |
| 01/22/2013 | US8357709 2,4-disubstituted pyrrolidine orexin receptor antagonists |
| 01/22/2013 | CA2672271C Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 01/22/2013 | CA2565695C Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder |
| 01/17/2013 | WO2013007168A1 Preparation and use of pyrrole and dihydropyrrole fused ring compound having insecticidal activity |
| 01/17/2013 | US20130018179 Processes for the convergent synthesis of calicheamicin derivatives |
| 01/17/2013 | US20130018159 Copolymerizable methine and anthraquinone compounds and articles containing them |
| 01/16/2013 | EP2545034A1 A process for amidation of pyrrole carboxylate compounds |
| 01/16/2013 | EP2544993A1 Method for producing a radioactive tracer |
| 01/16/2013 | CN102884045A Succinimide compound, lubricating oil additive, and lubricating oil composition |
| 01/16/2013 | CN102884044A Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 01/16/2013 | CN102884041A Cationic lipid |
| 01/16/2013 | CN102875439A Compound (E) 3-(1H-pyrryl-2-yl)ethyl acrylate and preparation method thereof |
| 01/16/2013 | CN102875438A Compound 3-(1H-pyrryl-2-yl)ethyl propionate and preparation method thereof |
| 01/16/2013 | CN102875437A Compound 3,5-dimethyl-2-pyrrylformaldehyde and preparation method thereof |
| 01/16/2013 | CN102875436A Compound 1H-pyrrole-2-carboxaldehyde and preparation method thereof |
| 01/16/2013 | CN102875413A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 01/16/2013 | CN101747253B Trisubstituted chiral lactam derivative and preparation method and application thereof |
| 01/16/2013 | CN101747251B Crystal of doripenem intermediate and preparation method thereof |
| 01/15/2013 | US8354545 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/15/2013 | US8354445 Inhibitors of histone deacetylase |
| 01/15/2013 | US8354444 Substituted pyrrolidine-2-carboxamides |
| 01/15/2013 | CA2702834C Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 01/10/2013 | WO2013006143A1 Process for producing an aminopropyne or enaminone |
| 01/10/2013 | WO2013005153A1 Biaryl derivatives as nachr modulators |
| 01/10/2013 | WO2013005045A1 Benzylamine derivatives as inhibitors of plasma kallikrein |
| 01/10/2013 | WO2013004591A1 Micronized crystals of atorvastatin hemicalcium |
| 01/10/2013 | WO2013004291A1 Cyclic amine derivatives as ep4 receptor agonists |
| 01/10/2013 | WO2013004290A1 Cyclic amine derivatives as ep4 receptor antagonists |
| 01/10/2013 | WO2013004190A1 Amino-propylene-glycol derivatives, preparation method and pharmaceutical composition and use thereof |
| 01/10/2013 | WO2012075287A3 Novel selective inhibitors of prolylcarboxypeptidase |
| 01/10/2013 | US20130012723 Methods and compounds for producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 01/10/2013 | US20130012701 Quaternary heteroatom containing compounds |
| 01/10/2013 | US20130012699 Amidium-based ionic liquids for carbon dioxide absorption |
| 01/10/2013 | CA2841042A1 Benzylamine derivatives as inhibitors of plasma kallikrein |
| 01/10/2013 | CA2839116A1 Cyclic amine derivatives as ep4 receptor antagonists |
| 01/09/2013 | EP2542524A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 01/09/2013 | EP2542089A1 Nuclear transport modulatiors and uses thereof |
| 01/09/2013 | CN102863428A Spiro-compounds taken as hepatitis c virus (HCV) inhibitor |
| 01/09/2013 | CN102863371A Fluoro dihydropyrrole or fluoro pyrrole |